TNF-α upregulates the A2B adenosine receptor gene: The role of NAD(P)H oxidase 4

Biochemical and Biophysical Research Communications

Volumn 375, Issue 3, 2008, Pages 292-296

  St Hilaire, Cynthia ^a   Koupenova, Milka ^a   Carroll, Shannon H ^a   Smith, Barbara D ^a   Ravid, Katya ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A2B adenosine receptor; Adenosine receptor; Gene regulation; NAD(P)H oxidase 4; Tumor necrosis factor alpha; Vascular smooth muscle cells

Indexed keywords

ADENOSINE A2 RECEPTOR; CYTOKINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TUMOR NECROSIS FACTOR ALPHA;

A2B ADENOSINE RECEPTOR GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; GENE; GENE CONTROL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTOR, ADENOSINE A2A; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 50849119080     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.059     Document Type: Article

References (41)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Hasko G., and Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25 (2004) 33-39
3. Hasko G., Kuhel D.G., Chen J.F., Schwarzschild M.A., Deitch E.A., Mabley J.G., Marton A., and Szabo C. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14 (2000) 2065-2074
4. Hasko G., Szabo C., Nemeth Z.H., Kvetan V., Pastores S.M., and Vizi E.S. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157 (1996) 4634-4640
5. Sitkovsky M.V., and Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?. Trends Immunol. 26 (2005) 299-304
6. Obata T. Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sci. 71 (2002) 2083-2103
7. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 775-787
8. Zhang J.G., Hepburn L., Cruz G., Borman R.A., and Clark K.L. The role of adenosine A2A and A2B receptors in the regulation of TNF-a production by human monocytes. Biochem. Pharmacol. 69 (2005) 883-889
9. Kreckler L.M., Wan T.C., Ge Z.D., and Auchampach J.A. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J. Pharmacol. Exp. Ther. 317 (2006) 172-180
10. Kolachala V., Asamoah V., Wang L., Obertone T.S., Ziegler T.R., Merlin D., and Sitaraman S.V. TNF-alpha upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cell Mol. Life Sci. 62 (2005) 2647-2657
11. Trincavelli M.L., Marroni M., Tuscano D., Ceruti S., Mazzola A., Mitro N., Abbracchio M.P., and Martini C. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J. Neurochem. 91 (2004) 1180-1190
12. Kolachala V., Asamoah V., Wang L., Obertone T.S., Ziegler T.R., Merlin D., and Sitaraman S.V. TNF-a upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cell. Mol. Life Sci. 62 (2005) 2647-2657
13. Dubey R.K., Gillespie D.G., Osaka K., Suzuki F., and Jackson E.K. Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. Hypertension 27 (1996) 786-793
14. Dubey R.K., Gillespie D.G., Mi Z., and Jackson E.K. Adenosine inhibits growth of human aortic smooth muscle cells via A2b receptors. Hypertension 31 (1998) 516-521
15. Wakeno M., Minamino T., Seguchi O., Okazaki H., Tsukamoto O., Okada K.I., Hirata A., Fujita M., Asanuma H., Kim J., Komamura K., Takashima S., Mochizuki N., and Kitakaze M. Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation (2006)
16. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606
17. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Int. Comp. Physiol. 285 (2003) R277-R297
18. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., and Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31 (2001) 1456-1464
19. Clempus R.E., Sorescu D., Dikalova A.E., Pounkova L., Jo P., Sorescu G.P., Schmidt H.H., Lassegue B., and Griendling K.K. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 42-48
20. Krause K.H. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn. J. Infect. Dis. 57 (2004) S28-S29
21. Leusen J.H., Verhoeven A.J., and Roos D. Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family. Front Biosci. 1 (1996) d72-d90
22. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4 (2004) 181-189
23. De Keulenaer G.W., Alexander R.W., Ushio-Fukai M., Ishizaka N., and Griendling K.K. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem. J. 329 Pt 3 (1998) 653-657
24. Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H., Busse R., and Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279 (2004) 45935-45941
25. Moe K.T., Aulia S., Jiang F., Chua Y.L., Wong M.C., and Dusting G.J. Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J. Cell. Mol. Med. 10 (2006) 231-239
26. Zhao Z., Francis C.E., and Ravid K. An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: its role in attenuating adenosine-induced increase in cAMP. Microvasc. Res. 54 (1997) 243-252
27. Yang D., Zhang Y., Nguyen H.G., Koupenova M., Chauhan A.K., Makitalo M., Jones M.R., St. Hilaire C., Seldin D.C., Toselli P., Lamperti E., Schreiber B.M., Gavras H., Wagner D.D., and Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Invest. 116 (2006) 1913-1923
28. Chomczynski P., and Sacchi N. Single step method of RNA Isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156
29. Mahadev K., Motoshima H., Wu X., Ruddy J.M., Arnold R.S., Cheng G., Lambeth J.D., and Goldstein B.J. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24 (2004) 1844-1854
30. St. Hilaire C., Yang D., Schreiber B.M., and Ravid K. B-Myb regulates the A2B adenosine receptor in vascular smooth muscle cells. J. Cell. Biochem. 103 (2008) 1962-1974
31. Kong T., Westerman K.A., Faigle M., Eltzschig H.K., and Colgan S.P. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20 (2006) 2242-2250
32. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
33. Rietschel E.T., Schletter J., Weidemann B., El-Samalouti V., Mattern T., Zahringer U., Seydel U., Brade H., Flad H.D., Kusumoto S., Gupta D., Dziarski R., and Ulmer A.J. Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation. Microb. Drug Resist 4 (1998) 37-44
34. Haddad J.J., and Land S.C. A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett. 505 (2001) 269-274
35. Ximenes V.F., Kanegae M.P., Rissato S.R., and Galhiane M.S. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch. Biochem. Biophys. 457 (2007) 134-141
36. O'Donnell B.V., Tew D.G., Jones O.T., and England P.J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290 Pt. 1 (1993) 41-49
37. Mattana J., Effiong C., Kapasi A., and Singhal P.C. Leukocyte-polytetrafluoroethylene interaction enhances proliferation of vascular smooth muscle cells via tumor necrosis factor-alpha secretion. Kidney Int. 52 (1997) 1478-1485
38. Tanaka H., Sukhova G., Schwartz D., and Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 12-18
39. Kreckler L.M., Wan T.C., Ge Z.-D., and Auchampach J.A. Adenosine inhibits tumor necrosis factor-{alpha} release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J. Pharmacol. Exp. Ther. 317 (2006) 172-180
40. Satriano J.A., Shuldiner M., Hora K., Xing Y., Shan Z., and Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J. Clin. Invest. 92 (1993) 1564-1571
41. Paysant J.R., Rupin A., and Verbeuren T.J. Effect of NADPH oxidase inhibition on E-selectin expression induced by concomitant anoxia/reoxygenation and TNF-alpha. Endothelium 9 (2002) 263-271